Free Trial
→ Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry.' (From Brownstone Research) (Ad) Free TEVA Stock Alerts

Teva Pharmaceutical Industries (TEVA) SEC Filings & 10K Form

Teva Pharmaceutical Industries logo
$16.74 -0.26 (-1.50%)
Closing price 03:59 PM Eastern
Extended Trading
$16.75 +0.00 (+0.01%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Teva Pharmaceutical Industries SEC Filings

Export to Excel
DateFilerForm TypeView
02/18/2025
11:38 AM		Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
7:06 AM		Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
3:06 PM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:00 AM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
6:03 PM		BRIDGER MANAGEMENT, LLC (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:04 PM		Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
10:39 AM		Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
9:34 AM		FMR LLC (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SC 13G
11/06/2024
3:06 PM		Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:00 AM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
6:40 AM		Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:06 AM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
08/14/2024
5:24 AM		Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
08/12/2024
3:09 PM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
6:32 AM		Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:35 AM		Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:30 AM		Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2024
3:06 PM		Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
6:00 AM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:01 AM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:00 AM		MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:03 AM		Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:38 AM		Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:41 AM		Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:23 AM		Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:27 AM		Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:14 AM		BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:17 AM		Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:20 AM		LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:45 AM		MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:47 AM		Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:49 AM		Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:51 AM		Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:53 AM		Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:36 AM		Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:38 AM		LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:42 AM		Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:31 AM		BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:33 AM		Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:25 AM		Shields Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:18 AM		Shields Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Grab This Altcoin Before Trump's Crypto Announcement (Ad)

Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.

Click here to check it out now
05/17/2024
6:41 AM		Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
7:30 AM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:36 AM		Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:01 AM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:12 PM		Teva Pharmaceutical Industries (Filer)
Form ARS
04/16/2024
3:16 PM		Teva Pharmaceutical Industries (Filer)
Form DEFA14A
04/09/2024
9:26 AM		Phoenix Holdings Ltd. (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SC 13G/A
03/07/2024
3:27 PM		Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:27 PM		Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:57 AM		Bergwerk Dov (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:48 AM		Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:52 AM		Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:54 AM		Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:40 AM		Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:43 AM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:45 AM		Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:37 AM		Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:TEVA) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Elon “obliterates” Bill Gates?
All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...
Altimetry | Sponsored
NVDA Crash Update
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...
Chaikin Analytics | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
My 2025 AI Blueprint
I first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...
Weiss Ratings | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
America cannot power AI
There’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...
Porter & Company | Sponsored